A discrete cluster of urinary biomarkers discriminates between active systemic lupus erythematosus patients with and without glomerulonephritis.
Carolina Landolt-MarticorenaStephenie D ProkopecStacey MorrisonBabak NoamaniDennisse BonillaHeather ReichJames ScholeyCarmen Avila-CasadoPaul R FortinPaul C BoutrosJoan E WitherPublished in: Arthritis research & therapy (2016)
A number of promising urinary biomarkers that correlate with the presence of active renal disease and/or renal biopsy changes were identified and appear to outperform many of the existing proposed biomarkers.